BioNTech SE (BNTX) Cash from Financing Activities (2018 - 2026)

BioNTech SE has reported Cash from Financing Activities for 8 years, with the latest figure at -$16.6 million in Q4 2025.

• Quarterly Cash from Financing Activities fell 113.39% year-over-year to -$16.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$59.7 million (down 20.26% YoY) and the FY2025 annual result came in at -$59.8 million, down 21.85% from the prior year.
• Cash from Financing Activities fell to -$16.6 million in Q4 2025 per BNTX's latest filing, from -$13.4 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $184.1 million in Q2 2021 and troughed at -$833.9 million in Q2 2022.
• A 5-year average of -$112.2 million and a median of -$14.2 million in 2023 frame the typical range for Cash from Financing Activities.
• The widest YoY moves for Cash from Financing Activities: up 1660329323.39% in 2022, down 118001159.55% in 2022.
• Over 5 years, Cash from Financing Activities stood at $55.94 in 2021, then slumped by 118001159.55% to -$66.0 million in 2022, then surged by 78.97% to -$13.9 million in 2023, then soared by 43.8% to -$7.8 million in 2024, then sank by 113.39% to -$16.6 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$16.6 million, -$13.4 million, and -$15.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.